n n n ‘. concat(e. i18n. t(“search. voice. recognition_retry”),’n
SAN DIEGO, Dec. 6, 2023 /PRNewswire/ — In a groundbreaking announcement today, PrecisePK solidifies an unprecedented partnership with Maza University, a monumental milestone in the field of pharmacology education in Argentina. Through a strategic collaboration with the famous Faculty of Pharmacy and Biochemistry, the University of Maza has the first establishment in Argentina to obtain a key software in pharmacokinetics.
“The acquisition of this software is of great importance for the educational and clinical network as it makes Maza University the first university in Argentina to acquire Bayesian-style precision dosing software for the training of its academics in pharmacokinetics. Clinical Pharmacokinetics Unit of the Faculty of Pharmacy Service of the Central Hospital, hospital point four of the Health System of the Province of Mendoza for the control of critical patients”, highlights the University of Maza, highlighting the strategic importance of this alliance.
This transformative educational project represents a major step forward, expanding the caliber of pharmacokinetics education across the country. Driven by proper research, the collaboration was initiated through the Pharmacology Chair within the educational unit. In particular, members of the university contribute their expertise to the prestigious Clinical Pharmacokinetics Unit of the Central Hospital of Mendoza, amplifying the consequent impact of this collaboration in the clinical field.
This strategic alignment between PrecisePK and Maza University symbolizes an unprecedented fusion of educational prowess and real-world applications. Maza University says: “This vital investment has been motivated through the constant initiative of educational activities, acquisition and implementation of wisdom. In reality, it will gain advantages for tens and thousands of professionals in the long run. “
“This program (PrecisePK) allows, based on the dosage of drugs in the blood of patients treated with antibiotics, anticonvulsants, or immunosuppressants, to predict the effective dose that they should receive on an individual and personalized basis to improve their state of health, with lower risk of adverse events, implying in precision medicine to both doctors and clinical and hospital pharmacists,” elucidates Maza University on the practical application of the PrecisePK system.
Furthermore, Maza University emphasizes, “Students from courses of Pharmacology I and II, Professional Practice of Pharmacy, and Clinical Pharmacy will be able to apply their knowledge and practice in the classroom and during pharmacy service at the Central Hospital with data from real patients, both clinical parameters and plasma concentration. For drugs with a narrow therapeutic range, students will be analyzing them and proposing to doctors the necessary dose adjustment for a better result in terms of health in the Intensive Care Units and Services, Cardiovascular Recovery, Transplant Unit, and Neurology,”
In summary, the partnership between PrecisePK and the University of Maza marks a transformative change in the teaching of pharmacology and the practice of clinical pharmacology in Argentina. This collaboration, focused on precision medicine and evidence-based practice, showcases PrecisePK as a cutting-edge technology in support of clinical resolution. Smart Healthcare Solutions, this alliance empowers clinical pharmacists, optimizing remedies and promoting antibiotic stewardship. Ultimately, this strategic union marks a vital step toward leveraging generation for patient care and advancing healthcare on a larger scale.
About Maza UniversityThe Juan Agustín Maza University was born on May 4, 1960, in Mendoza, as a non-profit civil society; becoming the first private university in the province and the ninth to be officially recognized at the national level. Today, Maza University has a presence in multiple projects, inter-institutional networks, and associations; establishing and strengthening agreements with important universities in the world, to provide better and greater opportunities to students and graduates.
About PrecisePKPrecisePK is a leading global provider of curative drug tracking software for precision model-based Bayesian assays (MIPDs). Leveraging real-time bedside support for medication dosing, cure analysis, local population modeling, AKI predictor, and other resources, the software is designed to streamline the charts needed to achieve individualized treatment and protect patient care, at the point of care. In addition to its powerful vancomycin AUC calculator, PrecisePK offers a wide diversity of drug modules that ease the flow of infectious disease charts and various other areas of healing, adding neurology, oncology, cardiology, and pulmonology. Visit the PrecisePK website for a free trial.
ContactChristy Xiechristy@precisepk. com
Check the content to download the multimedia:https://www. prnewswire. com/news-releases/precisepk-pioneers-model-informed-precision-dosing-and-pharmacokinetics-advancements-in-argentina-with-maza-university – 302007783Matrixhtml
SOURCE: PrecisaPK